Jeffrey Fendler - Primerica President
| PRI Stock | USD 271.72 1.51 0.56% |
President
Mr. Jeffrey S. Fendler is Executive Vice President, Chief Compliance and Risk Officer of the company since February 2014. He has served as Executive Vice President and Chief Compliance and Risk Officer of our company since February 2014. He served as President of Primerica Life, a subsidiary of Primerica, from 2005 through January 2014 and in various capacities at our company since 1980 since 2014.
| Age | 67 |
| Tenure | 10 years |
| Address | 1 Primerica Parkway, Duluth, GA, United States, 30099 |
| Phone | 770 381 1000 |
| Web | https://www.primerica.com |
Primerica Management Efficiency
The company has Return on Asset of 0.0423 % which means that on every $100 spent on assets, it made $0.0423 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.3248 %, implying that it generated $0.3248 on every 100 dollars invested. Primerica's management efficiency ratios could be used to measure how well Primerica manages its routine affairs as well as how well it operates its assets and liabilities. As of now, Primerica's Return On Capital Employed is increasing as compared to previous years. The Primerica's current Return On Equity is estimated to increase to 0.29, while Return On Tangible Assets are projected to decrease to 0.03. As of now, Primerica's Intangibles To Total Assets are increasing as compared to previous years. The Primerica's current Debt To Assets is estimated to increase to 0.14, while Total Assets are projected to decrease to under 13.6 B.Similar Executives
| Showing other executives | PRESIDENT Age | ||
| Masatoshi Koide | Aflac Incorporated | 60 | |
| Myles Lambert | Brighthouse Financial | 48 | |
| Carrie Jost | CNO Financial Group | N/A | |
| Eric Kirsch | Aflac Incorporated | 60 | |
| Zandra Haai | CNO Financial Group | N/A | |
| Matthew Zimpfer | CNO Financial Group | 57 | |
| June Howard | Aflac Incorporated | 54 | |
| Rocco Tarasi | CNO Financial Group | 49 | |
| Albert Riggieri | Aflac Incorporated | 68 | |
| Max Broden | Aflac Incorporated | 45 | |
| Nancy Sweet | CNO Financial Group | N/A | |
| Bruce Baude | CNO Financial Group | 59 | |
| Koji Ariyoshi | Aflac Incorporated | 65 | |
| John Kline | CNO Financial Group | 63 | |
| John Rosenthal | Brighthouse Financial | 62 | |
| Charles II | Aflac Incorporated | 62 | |
| Audrey Tillman | Aflac Incorporated | 56 | |
| Scott CPA | CNO Financial Group | 54 | |
| Steven Beaver | Aflac Incorporated | 59 | |
| Frederick Crawford | Aflac Incorporated | 60 | |
| Teresa White | Aflac Incorporated | 57 | |
Management Performance
| Return On Equity | 0.32 | ||||
| Return On Asset | 0.0423 |
Primerica Leadership Team
Elected by the shareholders, the Primerica's board of directors comprises two types of representatives: Primerica inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Primerica. The board's role is to monitor Primerica's management team and ensure that shareholders' interests are well served. Primerica's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Primerica's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Joel Babbit, Independent Director | ||
| Brett JD, Executive Counsel | ||
| Sanjeev Dheer, Independent Director | ||
| John Adams, Chief Executive Officer - Primerica Life Insurance Company of Canada | ||
| Tracy Tan, Executive CFO | ||
| Estee Faranda, Chief Executive Officer - PFS Investments | ||
| Nicholas Jendusa, Executive Officer | ||
| Peter Schneider, President | ||
| Donald Williams, Non-Executive Chairman of the Board | ||
| C Chambliss, Independent Director | ||
| Emily Rowe, Executive Vice President and Chief Actuary | ||
| Beatriz Perez, Independent Director | ||
| Lisa Brown, Executive Vice President Chief Administrative Officer | ||
| Gary Crittenden, Independent Director | ||
| Michael Adams, Executive Vice President and Chief Business Technology Officer | ||
| Cynthia Day, Independent Director | ||
| Julie Seman, Executive Vice President Primerica Life, Client Solutions, Strategic Markets and Training and Development | ||
| Nicole Russell, Senior Relations | ||
| P Benson, Lead Independent Director | ||
| Robert Peterman, Executive Vice President Chief Marketing Officer | ||
| Anthony Solazzo, Chief Executive Officer, E-TeleQuote Insurance, Inc. | ||
| John Addison, Non-Executive Chairman - Primerica Distribution, Director | ||
| Alison Rand, Chief Financial Officer, Executive Vice President | ||
| Michael Miller, Executive Vice President, Head of Corporate Development and Strategic Planning, President of Primerica Mortgage, LLC | ||
| Jeffrey Fendler, Executive Vice President, Chief Compliance and Risk Officer | ||
| Brett Rogers, Executive Vice President General Counsel | ||
| Gregory Pitts, Chief Operating Officer, Executive Vice President | ||
| William Kelly, Executive Vice President and Co-Head of Business Technology | ||
| Kathryn Kieser, Executive Vice President, Chief Reputation Officer - Investor Relations | ||
| Glenn Williams, CEO, Director and Member of Executive Committee | ||
| Barbara Yastine, Independent Director |
Primerica Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Primerica a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.32 | ||||
| Return On Asset | 0.0423 | ||||
| Profit Margin | 0.15 % | ||||
| Operating Margin | 0.35 % | ||||
| Current Valuation | 10.58 B | ||||
| Shares Outstanding | 33.37 M | ||||
| Shares Owned By Insiders | 0.61 % | ||||
| Shares Owned By Institutions | 93.97 % | ||||
| Number Of Shares Shorted | 272.89 K | ||||
| Price To Earning | 15.58 X |
Currently Active Assets on Macroaxis
When determining whether Primerica offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Primerica's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Primerica Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Primerica Stock:Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Primerica. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. For more detail on how to invest in Primerica Stock please use our How to Invest in Primerica guide.You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Is Life & Health Insurance space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Primerica. If investors know Primerica will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Primerica listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.143 | Dividend Share 3.3 | Earnings Share 19.94 | Revenue Per Share 90.798 | Quarterly Revenue Growth 0.107 |
The market value of Primerica is measured differently than its book value, which is the value of Primerica that is recorded on the company's balance sheet. Investors also form their own opinion of Primerica's value that differs from its market value or its book value, called intrinsic value, which is Primerica's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Primerica's market value can be influenced by many factors that don't directly affect Primerica's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Primerica's value and its price as these two are different measures arrived at by different means. Investors typically determine if Primerica is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Primerica's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.